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Abstract
Background: Over 75% of mental health problems begin in adolescence and primary care has been identified as
the target setting for mental health intervention by the World Health Organisation. The mobiletype program is a
mental health assessment and management mobile phone application which monitors mood, stress, coping
strategies, activities, eating, sleeping, exercise patterns, and alcohol and cannabis use at least daily, and transmits
this information to general practitioners (GPs) via a secure website in summary format for medical review.
Methods: We conducted a randomised controlled trial in primary care to examine the mental health benefits of
the mobiletype program. Patients aged 14 to 24 years were recruited from rural and metropolitan general practices.
GPs identified and referred eligible participants (those with mild or more mental health concerns) who were
randomly assigned to either the intervention group (where mood, stress, and daily activities were monitored) or
the attention comparison group (where only daily activities were monitored). Both groups self-monitored for 2 to 4
weeks and reviewed the monitoring data with their GP. GPs, participants, and researchers were blind to group
allocation at randomisation. Participants completed pre-, post-, and 6-week post-test measures of the Depression,
Anxiety, Stress Scale and an Emotional Self Awareness (ESA) Scale.
Results: Of the 163 participants assessed for eligibility, 118 were randomised and 114 participants were included in
analyses (intervention group n = 68, comparison group n = 46). Mixed model analyses revealed a significant group
by time interaction on ESA with a medium size of effect suggesting that the mobiletype program significantly
increases ESA compared to an attention comparison. There was no significant group by time interaction for
depression, anxiety, or stress, but a medium to large significant main effect for time for each of these mental
health measures. Post-hoc analyses suggested that participation in the RCT lead to enhanced GP mental health
care at pre-test and improved mental health outcomes.
Conclusions: Monitoring mental health symptoms appears to increase ESA and implementing a mental health
program in primary care and providing frequent reminders, clinical resources, and support to GPs substantially
improved mental health outcomes for the sample as a whole.
Trial Registration: ClinicalTrials.gov NCT00794222.
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Mental health problems are common in young people
with 75% of disorders beginning in adolescence and ado-
lescent onset posing a considerable risk factor for long
term psychological problems [1]. Adolescence is therefore
likely to be an important phase for early intervention with
primary care identified as the target setting in the World
Health Organisation strategy for mental health [2]. Gen-
eral Practitioners (GPs) are often the providers of first step
interventions for mental health (i.e. screening, monitoring,
and psychoeducation), initially managing mental health
concerns within their own clinical practice, then becoming
conduits or gatekeepers to second step and further mental
health care services (i.e. psychotherapy, medication, hospi-
talisation) when necessary [3,4]. Nevertheless, detection
and management of mental health problems in primary
care remains a challenge particularly with young people
[5]; it is estimated that GPs detect at best 50% of mental
health disorders [6,7]. Furthermore, 5.7% of adolescents
are diagnosed with major depressive disorder [8] and up
to 30% of young people experience mild depressive symp-
toms [9,10]. New methods are needed that focus on the
early stages of mental health problems before clinically
diagnosable mental health disorders are identified.
Poor recognition of symptoms by young people creates
a significant barrier to communicating, detecting, and
receiving help for mental health problems [11]. Research
suggests that most people do not recognise the symp-
toms of depression and are suspicious about effective
treatments [12]. Doctor related barriers to detection and
management of mental health symptoms include insuffi-
cient time for assessments, a lack of confidence in mana-
ging and treating mental health symptoms, and a lack of
systematic approaches to identify and provide evidence-
based interventions for psychological disorders [13].
Detection rates of psychological problems are not neces-
sarily associated with GP level of training in mental
health or adolescent health [7], suggesting that further
GP training in recognising mental health disorders may
not be the most effective avenue for increasing detection
rates.
There is some evidence that computerised screening, via
portable computers such as Personal Digital Assistants or
hand held touch pads (e.g. iPad) are both acceptable to
patients and physicians, and can increase detection rates
of health risk behaviours such as poor nutrition or exercise
[14,15]. Short duration self-monitoring programs involving
the completion of homework diaries have had some suc-
cess at reducing depressive symptoms [16] and can be run
on mobile phones [17,18]. Mobile phones provide a
unique avenue for early intervention of mental health pro-
blems as they are an ubiquitous accessory, with 100% mar-
ket penetration in Australia and Britain, and 67%
worldwide [19]. Involving technology, such as computers,
the internet or mobile phones in mental health programs
can engage and foster young people’si n v o l v e m e n t[ 2 0 - 2 2 ] .
Daily monitoring of mental health symptoms across time
(i.e. between appointments) via mobile phones may assist
young people in reducing their symptoms of mental health
problems before reaching clinically diagnosable disorders.
Further, daily monitoring data in addition to clinical
assessment may allow for greater matching of services to
patient needs and enhance pathways to care when second
step care is indicated. From the patient’s perspective, there
is evidence that self-monitoring, on its own, is a therapeu-
tic activity via increasing self-awareness [23], particularly
of one’s emotions, and leading to positive behaviour
change [24-26], and therefore in the context of first step
mental health care in primary care settings may lead to
therapeutic outcomes.
As the integration of “e-health” reforms into primary
care are considered a top priority [27], we have developed
a novel mobile phone mental health assessment and man-
agement tool, the Mobile Tracking Young People’sE x p e r i -
ences (mobiletype) program [17,18], designed for use in
primary care and other clinical settings [28]. The mobile-
type program monitors a young person’s mood, stress,
coping strategies and daily activities a number of times per
day, and their eating, sleeping, exercise patterns, and alco-
hol and cannabis use once per day. This information is
then uploaded to GPs, via a secure website and displayed
in summary reports for review [17]. Our pilot study sug-
gests that young people will monitor their mental health
symptoms for the purpose of reviewing this data with
their doctor and that both doctor and young person find
this a beneficial way of communicating information about
mental health and that the mobiletype program assisted
the doctor to understand their patient better [28].
The overall aim of this study was to investigate, via a
randomised controlled trial, a number of suggested bene-
fits found in our pilot studies of the mobiletype program.
This RCT was conducted as an effectiveness trial, in which
we were interested the utility of the mobiletype program in
the real world primary care setting. This paper reports on
the primary outcomes of the RCT, namely, the mental
health outcomes. We hypothesised that the mental health
outcomes of participants who complete the mobiletype
program and review the data with their GP will be lower
at post-test and 6 weeks post-test compared with those in
the attention comparison group.
Methods
Study design
The data presented here are the primary outcome data
from the mobiletype randomised controlled trial con-
ducted from 2009 to 2011. This was a multi-centre, multi-
regional, stratified (according to region), single blind,
attention-controlled study with balanced (1:1) individual
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ducted in Victoria, Australia in a manner to allow for strict
adherence to CONSORT reporting guidelines [29].
Recruitment
General practitioners
All general practitioners in the Goulburn Valley Region
and Albury/Wodonga Regions were invited to participate
in the study via the Regional Division of General Practice
(support units that service clinical practices within a
region). Regional participants were overrepresented in this
sample as mental health problems are an increasing con-
cern in rural areas. GPs in Melbourne were recruited via
the local Divisions of General Practice. Clinics that listed
an interest in adolescent health on the Melbourne General
Practice Network (http://www.mgpn.com.au) were parti-
cularly targeted. Participating GPs were trained in using
the mobiletype website and provided a study manual
which included the study procedure and a thorough range
of clinical support, including referral details of adolescent
friendly allied health professionals and services, youth-
friendly internet, email and phone support, and youth-
focused psychoeducation handouts and worksheets on a
range of mental health problems (this information was
also available on the mobiletype website). Continuing pro-
fessional development quality assurance points were avail-
able to GPs for their participation in the study. Weekly
reminder faxes were sent to all participating GPs and fort-
nightly phone calls to the GPs clinic (with the aim of
speaking to the participating GP, but this was not always
possible) were made to remind doctors of the study and to
provide an update on recruitment to the study.
Young people
To best approximate the real world primary care setting,
the following inclusion criteria were set: (1) aged 14 to 24
years, (2) speak proficient English and (3) have a mild or
more severe emotional/mental health issue as assessed by
their GP, or indicated by a K10 Symptom score greater
than 16 [30]. Participants were excluded if they had a
severe psychiatric or medical condition that prevented
them from complying with either the requirements of
informed consent or study protocol.
Intervention
Version 4 of the mobiletype program was used as the
intervention in this study which was created using Java
Platform, Micro Edition, in-house by the Murdoch Chil-
drens Research Institute. This program was written for
use with multiple models of mobile phones and firmware.
For the purposes of this trial participants were lent a
study mobile phone with either the mobiletype interven-
tion or comparison program downloaded onto it. Data
from the program was uploaded to a secure website con-
structed and hosted by MCRI as well as being encrypted
and stored on the mobile phones.
Participants were prompted to complete a mobiletype
entry by an auditory signal/beep emitted from the mobile
phone at random intervals in the blocks outlined in
Table 1. If no report was completed the phone emitted
one reminder signal after 5 minutes. Entries were time-
coded and saved. Participants were also able to complete
the program any time and were able to complete an
entry between 10 pm and 8 am although no trigger was
sent at this time. The night time entry (00:00-08:00) con-
sisted of the same questions as the afternoon questions
as shown in Table 1. Each report took approximately 1-3
minutes to complete.
Intervention group The intervention group monitored
themselves using the complete mobiletype program
which assessed 8 areas of functioning as developed and
pilotted in previous mobiletype studies [17,18], consisting
of current activities, location, companions, mood, recent
stressful events, responses to stressful events, alcohol use,
cannabis use, quality and quantity of sleep, and quantity
and type of exercise, and diet (meals, snacks, “junk-food,”
and “soft-drinks” consumed). Participants who responded
in a manner that indicated they were at risk of self-harm
or suicide activated the program’s high-risk alert, which
would automatically send an SMS to our on call psychol-
ogist/phone counsellor. The psychologist would then call
the young person and assess the risk of self-harm and
alert the participant’s local community assistance team if
necessary. The time of day each module assessing the
eight areas was delivered varied as displayed in Table 1.
Comparison group The attention comparison protocol
was designed to provide a data collection process similar
to the intervention group by controlling for the amount of
time spent engaged in the research methodology and the
attention given to them by health care professionals and
research staff [31]. The comparison group monitored
themselves using an abbreviated version of the mobiletype
program that assessed only current activities, location,
companions, quality and quantity of sleep, and quantity
and type of exercise, and diet. Importantly, the modules
pertaining mental health as per Table 1 (i.e. mood, stress,
alcohol and cannabis use) were removed.
Summary reports Data collected by the mobiletype pro-
gram (for both intervention and comparison groups) on
t h em o b i l ep h o n ew a ss e n tv i aS M St oas e c u r ew e b s i t e
constructed and hosted by MCRI, where it was automati-
cally collated and available for viewing. Data was also
encrypted and stored within phones, and all study phones
were factory reset upon collection. Each area of assess-
ment was displayed in graphs (i.e. daily mood graphs) or
in tables (i.e. daily alcohol intake). An individualised
summary report of the data was written following struc-
tured prescriptive guidelines by the first author (regis-
tered psychologist), or the second author under the
supervision of the first author and consisted of mood,
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resources and recommendations for the intervention
group. The comparison group also received individua-
lized summary reports consisting of maintaining well-
being (about their sleep, daily activities, diet, and
exercise) and useful resources and recommendations.
Outcome Measures
The primary outcome measure was the Depression, Anxi-
ety, Stress Scale (DASS) [32] 21 item response form,
which is Australian and has Australian norms and clini-
cally validated ranges. A high score indicates greater
depression, anxiety, or stress. Kauer et al. [23] proposed
that self-monitoring may affect mental health by increas-
ing emotional self-awareness (ESA). As there is no direct
measure of ESA, a scale was created by adapting the 20-
item Self Reflection and Insight Scale [33], the 10-item
Ruminative Response Scale [34] and the 12-item Meta-
Evaluation Scale [35]. The total ESA scale had 33 items
(the scale is available from the second author), scores ran-
ged from 1 to 132, with higher scores indicating more
ESA, and had high internal consistency (Cronbach’s alpha
= .83). Also included in the questionnaire package was
general demographic information, the Short-Form 12
Heath Survey [36], an adapted version of the AUDIT [37],
substance use (adapted from the Victorian Adolescent
Health Cohort Study [38]), The Adolescent Coping Scale
General Short Form [39,40]. Doctor-patient rapport,
patient satisfaction, and pathways to care were assessed
with the General Practice Assessment Questionnaire com-
munication subscale [41], The Session Rating Scale [42],
and The Party Project’s Exit Interview [43] assessed path-
ways to care being if the participant was prescribed medi-
cations, referred to a health professional, referred for
further testing, scans and/or X-rays, or provided other
advice and psychoeducation regarding mental health dur-
ing the most recent medical review. The pre-test, post-
test, and 6 week post-test questionnaire packages included
all of the above measures.
At pre-test, the GPs completed a questionnaire adapted
from Haller et al [7] assessing the participants presenting
concern, their current diagnostic information such as
duration and medication, severity of any physical and
mental health symptoms, and pathways to care imple-
mented in current appointment (medication prescribed,
referrals to other health professionals, and other inter-
ventions). GPs’ confidence in dealing with the patient
was measured with an adapted version of the SHO
Appraisal Form [44]. At post-test the above measures
were repeated and specific feedback regarding the useful-
ness, accuracy, helpfulness, and impact of mobiletype
program on clinical practice was sought.
Sample size
Recruitment of 200 participants was anticipated from 10
general practices. This sample size was based upon
Cohen’s [45] statistical testing for multiple regression with
two independent variables (to account for the mediating
variable and the outcome) to detect a medium effect with
80% power and a probability of a type I error of .05. A
medium effect size was selected as this was thought to be
clinically significant. The anticipated sample size of 200
was not met due to delays in recruitment during school
holidays and the H1N1 influenza pandemic. As a result, a
deadline was set for stopping recruitment, and a total of
118 participants were recruited.
Randomisation
Participants were randomised to either i) the mobiletype
monitoring intervention program group or (ii) the atten-
tion comparison program group; both groups also received
usual medical care. Randomisation was conducted electro-
nically, set up by an in-house computer programmer using
random seed generation at the individual-level and strati-
fied according to area (Melbourne, Goulburn Valley, and
Albury/Wodonga). Study mobile phones were allocated ID
numbers within areas (i.e. Melbourne01, Melbourne02)
and either the intervention or comparison mobiletype pro-
gram was loaded consecutively in a blinded fashion
according to the programmer’s concealed randomisation
Table 1 Modules included in each block of the mobiletype intervention and comparison programs.
Intervention Attention Comparison
Morning Noon Afternoon Evening Morning Noon Afternoon Evening
08:00-10:59 11:00-15:29 15:30-19:59 20:00-00:00 08:00-10:59 11:00-15:29 15:30-19:59 20:00-00:00
MODULE
Current Activity ✓✓✓✓✓✓✓✓
Stress ✓✓✓✓
Mood ✓✓✓✓
Alcohol Use ✓
Cannabis Use ✓
Sleep ✓✓
Diet ✓✓
Exercise ✓✓
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bourne, 50 Goulburn Valley and 50 Albury/Wodonga par-
ticipants. Researchers, participants, and GPs were blind to
randomisation pre-test. GPs and participants became
aware of the group allocation at the post-test when the
summary reports were reviewed. This study had Royal
Children’s Hospital Human Research Ethics Committee
approval (HREC: 28113) and was registered in Clinical-
Trials.gov (Reference: NCT00794222).
Procedure
Recruitment
In addition to treatment as usual, GPs screened their
patients for eligibility to the study, organised an appoint-
ment for interested participants with a research assistant
using an online booking form, a faxed referral form, or by
phone and completed a pre-test questionnaire. Partici-
pants met with a mobiletype research assistant within 5
days of referral to learn the study process, complete con-
sent forms, the pre-test questionnaire package, review the
mobiletype program and other features of the phone, and
complete a practice entry of the mobiletype program. To
protect doctor-patient confidentiality, parental consent
was only sought when parents were present during the GP
consultations; this process was approved by the Royal
Children’s Hospital Human Research Ethics Committee.
Participants were provided with a study manual that
described the research procedure and offered trouble-
shooting tips.
Mobile phone monitoring period
All participants borrowed a Sony Ericsson Z750i mobile
phone containing the mobiletype program for the study
period. Information regarding the development and testing
of the mobiletype program has been previously published
[18,46]. Participants were requested to complete at least
two mobiletype entries a day until they returned for their
medical review in 2-4 weeks; participants and GPs were
advised that 2-4 weeks was the ideal monitoring period.
Participants were given a SIM card containing $30 in
credit as partial reimbursement for their time and phone
credit used.
Post-test review, 6-week post-test, and 6 month post-test
assessments Upon completion, participants reviewed the
self-monitoring data with their GP on the mobiletype
website. Young people completed a post-test assessment
immediately following this appointment, again at six
weeks and six months after this post-test review (6-
month post-tests not included in the current analysis).
GPs completed a post-test questionnaire immediately
after the appointment. Questionnaires were completed
online, over the phone with a research assistant, or via a
mailed hardcopy survey. Participants were given a $20
gift card for each follow up survey completed (maximum
of $60 for all questionnaires completed).
Analyses
Initially, to ascertain differences between groups in ESA,
an intention to treat (ITT) mixed model analysis was con-
ducted using SPSS v17.0.0 with the MIXED procedure.
Survey time was entered as a continuous variable in weeks
( 0 ,3 ,a n d9 ) .S u b s e q u e n tt ot h i s ,I T Tm i x e dm o d e la n a -
lyses were again employed to test the primary mental
health outcome. As planned contrasts were pivotal to
interpretation of the mental health outcomes, the survey
time was entered as categorical variable for these analyses.
The mixed model method uses all available data, all parti-
cipants at point of randomisation, without losing any
cases, assuming that data is missing at random (MAR)
[47]. All mixed models employed restricted maximum
likelihood estimation method, and included subject identi-
fication number as a random effect and employed the
time variable to create individual random slopes.
In terms of clustering, due to the number of GPs
involved and the relatively small clusters within GPs, clus-
tering at the GP did not provide a better approximation of
the intraclass correlation coefficient than at the individual
level. Geographic region was then considered as a proxy
clustering variable, which returned a very low intraclass
correlation coefficient of 0.007. As region clustering did
not significantly contribute to the mixed model, clustering
was not included. Multiple comparison adjustments (Bon-
ferroni post-hoc style) were applied to subsequent a priori
contrasts within the mental health mixed models, and
Cohen’s d measured the effect sizes of these contrasts [45].
T h ea b o v ea n a l y s e sw e r er e p e a t e du s i n gam i n i m u m
effective dosage approach which only included participants
who completed the minimum participation in the program
(completing the recommended level of mobiletype entries:
at least two entries per day for 14 days).
Results
Recruitment
Data collection took place between the 16
th April 2009
and 28
th January 2011. Of the 103 GPs who agreed to par-
ticipate, 35 actively recruited young people for the study.
These contributing GPs were from 26 different practices
in the three recruitment areas: 12 in greater Melbourne, 7
in Albury/Wodonga and 7 in the Goulburn Valley, result-
ing in an overrepresentation of general practices recruited
in rural areas; 75% of Australian general practices are
located in capital cities and suburbs [48]. Only 0.1% of
Victorians live in remote areas and therefore were not tar-
geted in this study [49]. As seen in Figure 1, 137 young
people accepted the invitation to join the study, of whom
118 began the recruitment process. Four participants were
excluded post randomisation (2 became too unwell to par-
ticipate, one was incarcerated, and one gave invalid
responses to all pre-test measures), resulting in a final
sample of 114 young people which was sufficient to detect
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Due to a failure to recruit the expected sample of 200 par-
ticipants, there are different numbers of participants in the
comparison and intervention groups, however, a test of
the binomial distribution indicated that this difference was
not significant with 69 out of 118 participants randomly
allocated to the intervention group (P = .080). The total
number of participants assessed for eligibility was difficult
 
Figure 1 Flow diagram of the study process.
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patients who met the inclusion criteria and were either
not approached to participate or who declined when
invited to participate. Therefore the number of patients
assessed for eligibility presented in Figure 1 is likely to be
underrepresented.
In total, 63.2% of participants (72/114) completed all
questionnaires and 84.2% of participants (96/114) com-
pleted questionnaires at two or more time points; several t-
tests and c
2 tests were conducted with no significant differ-
ences found between participants who completed all ques-
tionnaires and those who missed questionnaires. Therefore
all 114 participants were included in the analyses. Three
out of 114 participants (2.6%) did not complete the pre-
test questionnaire, but went on to complete the mobiletype
entries and post-tests. Sixteen participants (14%) were con-
sidered lost to follow-up, as they did not complete both the
post-test and the 6 week post-test questionnaires.
Demographics
No statistically significant differences in demographic
information were found between the intervention and
comparison group on any pre-test measures, as seen in
Table 2.
Participants in the intervention group completed an
average of 3.3 mobiletype entries each day (SD = 1.4,
range 1-8 per day) and completed the program from one
to 34 days with a mean of 14. 6 days completed (SD =
6.3). In the comparison group, participants completed an
average of 4 mobiletype entries per day (SD = 1.8, range
1-12), and completed the program for eight to 25 days
with a mean of 15.2 days completed (SD = 4.4). The
minimum effective dose of the program was considered
to be completing the mobiletype program two times a
day for at least 14 days. As can be seen in Table 2, 36
(52.9%) participants in intervention and 28 (60.9%) in
comparison received a minimum dose.
Missingness
In order to satisfy the mixed model assumption of MAR,
baseline demographics variables were compared between
those with available and those with missing DASS out-
comes at the post-test (30/114) and at the 6-week post-
test (27/114) periods. A significant association was found
between immediate follow-up survey completion and
cigarette smoking, c
2(1) = 3.92, p = .048, with a higher
proportion of those missing (72.41%) having smoked a
cigarette than those completing the survey (51.2%). This
was again found in the 6-week post-test, c
2(1) = 10.74, p =
.001, with 84.62% of those missing the survey period
reporting previously having smoked a cigarette, compared
to 48.24% of those who completed the survey. No other
significant associations/differences were found at either
survey period.
Outcome-Intention To Treat
Observed ESA and DASS mean differences were
assessed at each time point using independent samples
Table 2 General demographics of participants in the comparison and intervention groups
Comparison Group
N (%)
Intervention Group
N (%)
P
Total Number 46 (40.4%) 68 (59.60%)
14 days completed 28 (60.9%) 36 (52.9%) .330
Area
Melbourne 14 (30.4%) 28 (42.6%) .265
Goulburn Valley 21 (45.7%) 21 (29.4%)
Albury/Wodonga 11 (23.9%) 19 (27.9%)
Male Participants 17 (37.0%) 15 (22.1%) .082
Mean (SD) Age, years 17.4 (3.2) 18.5 (3.2) .059
Ethnic Identification
a 4 (9.1%) 10 (22.7%) .365
Employment
Employed 7 (15.2%) 18 (26.5%) .212
Unemployed 4 (8.7%) 9 (13.2%)
Student 35 (76.1%) 41 (60.3%)
Drug related items
a
Ever had alcohol 38 (86.4%) 59 (88.1%) .792
Ever been drunk 31 (70.5%) 53 (79.1%) .299
Ever had a cigarette 25 (56.8%) 38 (56.7%) .992
Ever tried marijuana 18 (40.9%) 33 (49.3%) .388
Ever tried other
b drugs 10 (22.7%) 26 (38.8%) .077
Note:
a n = 111,
bsedatives, tranquilizers, amphetamines, analgesics, inhalants, cocaine, LSD and heroin.
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f o u n di no b s e r v e dE S As c o r e sb e t w e e ng r o u p sa tt h e6 -
week post-test, with the intervention group mean ESA
6.6 points higher than the comparison, t(80) = 2.60, p =
.011. Also, the intervention group reported significantly
higher stress than the comparison group at pre-test,
with a mean difference of 3.4, t(109) = 2.06, p = .042
Linear mixed models were applied to the ESA, the
depression, anxiety, and stress subscales separately.
Emotional Self-Awareness
Results from the ESA mixed model analysis showed no
significant group (b = 1.01, P = .635) or time main effects
(b = 0.09, P = .675) but a significant interaction effect of
group × time, (b =0 . 5 9 ,P = .048), signifying different
ESA patterns over time between groups. The observed
means in Table 3 indicate that ESA increased in the
intervention group from baseline to 6 week post-test,
where as it remained the same from baseline to 6 week
post-test in the attention comparison group. The size of
effect of this difference at 6 weeks post-test was d=0.58,
and according to Cohen [51], this is a medium size of
effect.
Depression
There was no significant main effect for group, F(1,
110.48) = 0.19, p = .668), or interaction effect of group ×
time, F(2, 86.78) = 0.32, p = .729, but a significant main
effect for time was found for depression, F(2, 86.78) =
14.63, p < .001. Subsequent contrasts of the estimated
marginal means found a significant total group mean
decrease of 6.59 points between baseline and 6-week
post-test, t(96.32) = 5.26, p < .001, which was a medium
size of effect (d = 0.53), a significant drop of 3.17 points
from pre- to post-test, t(86.39) = 3.56, p = .001 (d =
0.37), and a further decrease of 3.42 from post- to 6-week
post-test, t(81.21) = 2.97, p =. 0 0 4( d =0 . 3 0 ) .T h ee s t i -
mated depression scale means and standard errors for
each group across time are displayed in Figure 2.
Anxiety
There was no significant main effect for group, F(1,
114.59) = 0.86, p = .356, or interaction effect of group ×
time, (F(2, 90.42) = 1.99, p = .142), but a significant
main effect for time was found for the anxiety scale, F(2,
90.42) = 4.11, p = .020. Subsequent contrasts of the esti-
mated marginal means found a significant total sample
mean decrease 2.49 points from pre-test to 6-week post-
test, t(93.35) = 2.76, p =. 0 0 7w i t ham e d i u ms i z eo f
effect (d = 0.46), no significant further contrasts were
significant. The estimated anxiety scale means and stan-
dard errors for each group across time are displayed in
Figure 3.
Stress
There was no significant main effect for group, F(1,
107.04) = 1.81, p = .181, or interaction effect of group ×
time, F(2, 86.41) = 1.52, p = .225.As i g n i f i c a n te f f e c tf o r
time was found, F(2, 86.41) = 8.38, p < .001, with post-hoc
analyses showing a significant whole sample decrease of
4.19 points between pre- and 6-week post-test, t(91.63) =
4.08, p < .001 and an above medium size of effect (d =
0.57), but no significant differences between pre- and
post-test, nor post- and 6-week post-test. The estimated
stress scale means and standard errors for each group
across time are displayed in Figure 4.
Table 3 Observed means, standard deviations, 95% confidence intervals, sample size and mean differences f or each
group at pre-, post- and 6-week post-test
Comparison Group Intervention Group Difference
N M (SD) 95% CI N M (SD) 95% CI M diff P d
ESA
Pre-test 42 60.6 (11.9) 56.9-64.3 62 61.7 (12.1) 58.7-64.8 1.1 .65 0.09
Post-test 32 63.1 (11.1) 59.1-67.1 46 64.7 (10.9) 60.9-67.4 1.0 .69 0.09
6-week 35 62.2 (11.6) 58.2-66.1 47 68.9 (11.2) 65.5-72.1 6.6 .01 0.58
Depression
Pre-test 44 19.4 (10.9) 16.1-22.7 67 20.4 (11.0) 17.8-23.1 1.0 .63 0.09
Post-test 33 15.2 (8.9) 12.1-18.3 50 16.3 (10.8) 13.3-19.4 1.1 .63 0.11
6-week 36 12.5 (11.8) 8.5-16.5 50 13.5 (10.5) 10.5-16.5 1.0 .69 0.09
Anxiety
Pre-test 43 11.1 (8.1) 8.6-13.6 67 14.1 (9.7) 11.7-16.5 3.1 .09 0.26
Post-test 33 10.5 (8.0) 7.7-13.3 50 11.2 (9.1) 8.6-13.7 0.7 .73 0.25
6-week 35 10.4 (9.6) 7.1-13.7 50 9.8 (9.3) 7.1-12.4 0.6 .76 0.07
Stress
Pre-test 44 16.9 (7.9) 14.5 -19.3 65 20.4 (8.9) 18.2-22.6 3.5 .04 0.40
Post-test 33 15.8 (8.0) 12.9-18.6 50 17.0 (9.4) 14.3-19.7 1.2 .53 0.14
6-week 35 13.1 (10.4) 9.6-16.7 50 15.2 (8.6) 12.8-17.6 2.1 .32 0.22
Note: Observed scores provided. N = number of participants used to calculate the mean (M), standard deviation (SD) and 95% confidence interval (CI), Mean
difference calculated using t-tests, d = effect size (Cohen’s d [51]).
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ticipants who completed ‘a minimum dose’ of monitoring
(completion of 2 entries each day for at least 14 days).
These results were similar to the ITT results with a signifi-
cant effect of time for depression, F(2, 50.75) = 6.28, p =
.004, with the size of effect for time being a 6.08 point
decrease from pre- to 6-week post-test, t(58.02) = 3.53, p =
.001 (d = 0.47), and no other significant effects for depres-
sion. The main effect of time for anxiety was no longer sig-
nificant, and there were no other significant effects. There
was a significant effect of time for stress, F(2, 50.05) = 4.21,
p = .020, with a decrease of 4.25 points from pre- to 6-
week post-test, t(54.29) = 2.89, p =. 0 0 5( d =0 . 3 9 ) ,a n dn o
other significant effects for stress.
Post-hoc Analyses
Post-hoc analyses were conducted to investigate the above
findings that across the whole sample depression, anxiety
and stress scale scores decreased by a medium size of
effect from pre-test to 6 weeks post-test. One possible
explanation is that the attention comparison was also an
active intervention because participation in the trial lead
to changes in GP management of mental health concerns
for all participants. The Party Project’s Exit Interview [43]
at pre-test and post-test assessed pathways to care being if
the participant was prescribed medications, referred to a
health professional, referred for further testing, scans and/
or X-rays, or provided other advice and psychoeducation
regarding mental health during the medical review by
their GP. For the sample as a whole, 91.7% (100/109)
received at least one and 55.0% (60/109) received at least
two “pathways to care” in the pre-test medical review.
Interestingly, there was not one predominant pathway or
intervention, 56.0% of the sample was prescribed medica-
tions, 54.1% referred to a health care professional, 38.5%
received other advice or psychoeducation about mental
health, and 25.7% were referred for further tests. This find-
ing suggests that GPs were intervening regarding mental
health for all participants at the pre-test medical review,
rather than waiting for further information from the mobi-
letype program.
Discussion
The aim of this study was to conduct a randomised con-
trolled effectiveness trial to examine the mental health
benefits of adding the mobiletype program and GP
review of the mobiletype data to usual medical care of at-
risk young people. The intervention group had an
increase of ESA over time with a significant effect of the
mobiletype program on ESA between pre- and 6-week
post-test when compared to the attention comparison
group. Results suggest that the self-monitoring interven-
tion program increases young people’sE S Ad u r i n gs e l f -
monitoring, between pre- and post-test, but this effect
was not significant until 6 weeks after completion of the
Figure 2 Estimated marginal means (and standard errors) of
depression scale for groups over time.
Figure 3 Estimated marginal means (and standard errors) of
the anxiety scale for groups over time.
Figure 4 Estimated marginal means (and standard errors) of
the stress scale for groups over time.
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Page 9 of 13program. Nevertheless, the mobiletype intervention
group’s mental health outcomes did not improve signifi-
c a n t l ym o r et h a nt h ea t t e n t i o nc o m p a r i s o ng r o u pa t
post-test or 6 weeks. For the sample as a whole, however,
there was a substantial decrease in each of the depres-
sion, anxiety, and stress scores from pre-test to 6 weeks
post-test and this decrease was a medium size of effect
for each scale, suggesting that both groups improved in
mental health outcomes substantially from pre-test to 6
weeks post-test. The decrease in mental health symptoms
6 weeks after the program may be explained by the effect
of young people having increased their awareness of their
emotions. A secondary outcomes paper from this study
further explores the possible mediating effect of ESA on
depressive symptoms [52].
Further investigation of the mental health outcomes was
warranted because the size of the decrease in depression,
anxiety, and stress symptoms was greater than one would
expect from simple retest effects alone [53,54]. Post-hoc
analyses of GP behaviour at pre-test suggested that in fact
GPs were unexpectedly acting to manage mental health
during the pre-test review in at least one manner for 92%
of the participants, without waiting for further information
from the mobiletype monitoring data, summary report and
recommendations. As this was an effectiveness trial, GPs
were instructed to simply add mobiletype to usual medical
care: there was no specific instruction to wait for mobile-
type data before referring, prescribing, or implementing
other patient management strategies (nor would this have
been ethical). In this study, GPs received frequent contact
and reminders from the research team thus raising the sal-
iency of youth mental in clinical care, and were also pro-
vided with comprehensive locally relevant clinical
resources (referral sources and psychoeducation hand-
outs). Further, as the general rate of return to follow up
review appointments in primary care can be unpredictable
particularly with young people [55,56], it is understandable
that GPs felt the need to manage mental health symptoms
when they first present rather than wait for further data
and risk the possibility of the patient not returning. In this
study we included an “attention comparison” group rather
than wait-list control due to ethical considerations, thus
increasing the testing rigour of the intervention, but also
increasing the likelihood of non-specific placebo effects on
outcome measures due to the attention comparison parti-
cipants also receiving an intervention of sorts [57]. The
results of this trial suggest that a self-monitoring program
which monitors young people’s mood, stress, and coping
can increase young people’s awareness of their emotions
more than a program which only monitors general health
factors. Self-monitoring may assist young people to
become aware of emotions and stressors and therefore
prepare themselves for more adaptive coping strategies.
This study also suggests that engaging GPs in a mental
health trial, providing frequent reminders, clinical
resources and referral pathways, a patient self-monitoring
program (as the attention comparison group also self-
monitored) and assisting patients to return for medical
reviews, leads to positive mental health outcomes for
patients.
Furthermore, this RCT was conducted with a view of
representing a wide variety of young people who visit GPs
with a range of medical and psychological problems and
severity of problems. Therefore the results of this study
are applicable to this age group in general. Nevertheless,
compared to data from the Australian Bureau of Statistics,
the rural sample in this study is overrepresented, with
53.8% of general practices located in rural Victoria partici-
pating this this study compared to 24% of general practices
located in rural Victoria in the population [48]. In addi-
tion, there was an overrepresentation of female patients
with 80.4% female patients recruited in the current sample
compared to 53% of females that seek treatment in general
health care practices.
Limitations
A cluster randomised controlled trial with a usual medical
care control group in which GPs or clinics were rando-
mised rather than individuals may have been a more appro-
priate design for this intervention. This design was rejected
for the current study, however, in preference for a more rig-
orous attention comparison group and individual randomi-
sation, as it would have been logistically impossible for GPs
and participants to be blinded to randomisation at recruit-
ment in a cluster RCT and there is considerable potential
for the introduction of bias in unblinded cluster RCTs
when inclusion to the study is based upon GP referral (i.e.
comparison GPs may only refer less severe patients) and
participant consent is required (i.e. comparison participants
may be less likely to consent) [58]. The inclusion of a wait-
list control or “usual medical care only” group in this study
would have allowed for comparison and testing of the sub-
stantial decrease in depression, anxiety, and stress in the
mobiletype and attention comparison groups to a more
natural control group. Nevertheless, the pre-test pathways
to care implemented at baseline by GPs may also have
occurred for a treatment as usual group and may have
decreased mental health symptoms in both groups, thereby
reducing the power needed to detect a significant difference
between the groups. A larger sample size, or a wait-list con-
trol group, would be needed to determine if there was a dif-
ference in depressive symptoms between groups [59,60].
Participant heterogeneity no doubt decreased the power of
this trial, yet, a significant interaction effect was found for
ESA. It appears, however, that the mental health interven-
tion implemented by the GPs at baseline “trumped” or
superseded any therapeutic effect of increasing ESA may
have on mental health. As this was an effectiveness trial,
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approximate to the real world primary care setting and
hence there was a range of severity in mental health, famil-
iarity of patients to GPs, and current mental health treat-
ment programs. Finally, the random outcome of uneven
groups due to cessation of recruitment before completion
of the randomisation list also reduced the power of the
study to find an effect between the intervention and atten-
tion comparison groups. A greater sample size and more
even distribution between groups may have lead to more
equivalent baseline means.
There has been much discussion internationally about
the need to support GPs in the detection and management
of mental health [61], with the WHO producing a number
of reports and strategies papers regarding this [2]. Chan-
ging GP mental health related practice and patient out-
comes in primary care has proven difficult with one
review citing that only 21 out of 36 RCTs which imple-
mented a number of either intensive plans, protocols,
nurse led-care, and specialist assistance for mental health
care in primary care lead to positive mental health out-
comes for patients [61,62]. The current mobiletype study
included many aspects of two large successful primary
care RCT mental health interventions [63,64], for example,
screening, clinician education, patient-specific reminders
for appointments and patient care by the research team,
and showed an overall mental health benefit for the sam-
ple as a whole and demonstrated that technology, particu-
larly mobile phones, can be used in clinical settings and
may provide GPs and young people with an avenue for
combating the early symptoms of mental health problems
before a clinically diagnosable disorder presents. Whilst
this study does not demonstrate any additional benefits of
monitoring specific mood, stress, coping, alcohol and can-
nabis use and general health factors compared to monitor-
ing general health factors alone, further research using this
methodology with larger sample sizes and a waitlist con-
trol seems warranted.
Conclusions
We conducted the first RCT of a mobile phone applica-
tion in the mental health assessment and management of
youth mental health in primary care. We found that
actively monitoring one’s mental health symptoms using
mobile phones led to increased emotional self-awareness.
Further, that implementing a mental health program
using technology in primary care and providing frequent
reminders, clinical resources and support to GPs sub-
stantially improved mental health outcomes for the sam-
ple as a whole.
Acknowledgements
This study was supported by research grants from the Telstra Foundation
and The Shepherd Foundation, and was supported by the Victorian
Government’s Operational Infrastructure Support Program. Sylvia Kauer
received an Ian Scott PhD scholarship funded by Australian Rotary Health. Be
Interactive provided telecommunication support. Telstra Corporation
provided pre-paid SIM cards and telecommunication support. Sony Ericsson
provided 40 mobile phones for use in this study.
Author details
1Murdoch Childrens Research Institute, University of Melbourne.
2Royal
Children’s Hospital, University of Melbourne.
3Department of General
Practice, University of Melbourne.
4School of Behavioural Science, University
of Melbourne, Australia.
Authors’ contributions
SCR conceived of, designed, and implemented the study, she also
participated in the analyses and drafted the manuscript. SK participated in
the conception, design, and implementation of the study, participated in the
analyses and contributed to the drafting of the manuscript. SJCH conducted
the analyses and participated in drafting the manuscript. AHDC coordinated
the implementation of the study and contributed to drafting the
manuscript. ASK contributed to the design of the study, collected data for
the study and contributed to drafting the manuscript. LAS and GCP both
contributed to the design of the study and drafting of the manuscript. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 1 August 2011 Accepted: 29 November 2011
Published: 29 November 2011
References
1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime
prevalence and age-of-onset distributions of DSM-IV disorders in the
national comorbidity survey replication. Archives of General Psychiatry
2005, 62:593-602.
2. WHO: Integrating mental health into primary care: a global perspective.
Geneva: World Health Organization and World Organization of Family
Doctors (Wonca); 2008.
3. van Straten A, Seekles W, van’t Veer-Tazelaar NJ, Beekman ATF, Cuijpers P:
Stepped care for depression in primary care: what should be offered
and how? Medical Journal of Australia 2010, 192(11 Suppl):S36-S39.
4. Hickie IB, Groom GL, McGorry PD, Davenport TA, Luscombe GM: Australian
mental health reform: time for real outcomes. Medical Journal of Australia
2005, 182:401-406.
5. Raine R, Lewis L, Sensky T, Hutchings A, Hirsch S, Black N: Patient
determinants of mental health interventions in primary care. British
Journal of General Practice 2000, 50(457):620-625.
6. Hickie IB, Davenport TA, Naismith SL, Scott EM: Conclusions about the
assessment and management of common mental disorders in Australian
general practice. Medical Journal of Australia 2001, 175(S):52-55.
7. Haller DM, Sanci LA, Sawyer SM, Patton GC: The identification of young
people’s emotional distress: A study in primary care. British Journal of
General Practice 2009, 59(560):e61-e70.
8. Costello EJ, Erkanli A, Angold A: Is there an epidemic of child or
adolescent depression? Journal of Child Psychology and Psychiatry 2006,
47(12):1263-1271.
9. Andrews G, Szabo M, Burns J: Preventing major depression in young
people. British Journal of Psychiatry 2002, 181:460-462.
10. Lewinsohn PM, Hops H, Roberts RE, Seeley JR, Andrews JA: Adolescent
psychopathology: I. Prevalence and incidence of depression and other
DSM-III–R disorders in high school students. Journal of Abnormal
Psychology 1993, 102(1):133-144.
11. Rickwood D, Cavanagh S, Curtis L, Sakrouge R: Educating young people
about mental health and mental illness: evaluating a school-based
programme. International Journal of Mental Health Promotion 2004, 6:4-13.
12. Jorm AF: Mental health literacy. Public knowledge and beliefs about
mental disorders. British Journal of Psychiatry 2000, 177:396-401.
13. Hickie IB, Fogarty AS, Davenport TA, Luscombe GM, Burns J: Responding to
experiences of young people with common mental health problems
attending Australian general practice. Medical Journal of Australia 2007,
187(7 Suppl):S47-S52.
Reid et al. BMC Family Practice 2011, 12:131
http://www.biomedcentral.com/1471-2296/12/131
Page 11 of 1314. Stevens J, Kelleher KJ, Gardner W, Chisolm D, McGeehan J, Pajer K,
Buchanan L: Trial of computerized screening for adolescent behavioral
concerns. Pediatrics 2008, 121(6):1099-1105.
15. Olson AL, Gaffney CA, Hedberg VA, Gladstone GR: Use of inexpensive
technology to enhance adolescent health screening and counseling.
Archives of Pediatrics & Adolescent Medicine 2009, 163(2):172-177.
16. Stice E, Shaw H, Bohon C, Marti CN, Rohde P: A meta-analytic review of
depression prevention programs for children and adolescents: factors
that predict magnitude of intervention effects. Journal of Consulting and
Clinical Psychology 2009, 77(3):486-503.
17. Kauer S, Reid S, Sanci L, Patton G: Investigating the utility of mobile
phones for collecting data about adolescent alcohol use and related
mood, stress and coping behaviours: Lessons and recommendations.
Drug & Alcohol Review 2009, 28(1):25-30.
18. Reid SC, Kauer SD, Dudgeon P, Sanci LA, Shrier LA, Patton GC: A mobile
phone program to track young people’s experiences of mood, stress
and coping. Development and testing of the mobiletype program. Social
Psychiatry and Psychiatric Epidemiology 2009, 44(6):501-507.
19. World Telecommunications/ICT Indicators Electronic Database. [http://
www.itu.int].
20. Walsh SP, White KM, Young RM: Over-connected? A qualitative
exploration of the relationship between Australian youth and their
mobile phones. Journal of Adolescence 2008, 31(1):77-92.
21. Zhao S, Grasmuck S, Martin J: Identity construction on Facebook: digital
empowerment in anchored relationships. Computers in Human Behavior
2008, 24:1816-1836.
22. Hollon SD, Muñoz RF, Barlow DH, Beardslee WR, Bell CC, Bernal G,
Clarke GN, Franciosi P, Kazdin AE, Kohn L, et al: Psychosocial intervention
development for the prevention and treatment of depression:
promoting innovation and increasing access. Biological Psychiatry 2002,
52(6):610-630.
23. Kauer S, Reid S, Jackson H, Jorm T: The phenomenon of insight and
preliminary findings for preventing depression: self-monitoring via
mobile phones. ’ASPR Poster Presentations’ Australian and New Zealand
Journal of Psychiatry 2007, 41:A496.
24. Kazantzis N: Power to detect homework effects in psychotherapy
outcome research. Journal of Consulting and Clinical Psychology 2000,
68(1):166-170.
25. Abueg FR, Colletti G, Kopel SA: A study of reactivity: the effects of
increased relevance and saliency of self-monitored smoking through
enhanced carbon monoxide feedback. Cognitive Therapy and Research
1985, 9:321-333.
26. Ewart CK: Self-observation in natural enviroments: reactive effects of
behavior desirability and goal-setting. Cognitive Therapy and Research
1978, 2:39-56.
27. Van Der Weyden MB: General practice and e-health reform. Medical
Journal of Australia 2010, 193(2):69.
28. Reid S, Kauer S, Sanci L, Patton G: Please turn your mobiles on in our
clinic: a mobile phone mental health monitoring program and website
interface for detection and management of adolescent mental health in
clinical settings. ’ASPR Poster Presentations’ Australian and New Zealand
Journal of Psychiatry 2007, 41:A499.
29. Altman DG, Schilz KF, Moher D, Egger M, Davidoff F, Elbourne D,
Gotzsche PC, Lang T: The revised CONSORT statement for reporting
randomised trials: explanation and elaboration. Annals of Internal Medicine
2001, 134(8):663-694.
30. Andrews G, Slade T: Interpreting scores on the Kessler Psychological
Distress Scale (K10). Australian and New Zealand Journal of Public Health
2001, 25(6):494-497.
31. LIndquist R, Wyman JF, Talley KMC, Findorff MJ, Gross CR: Design on
control-group conditions in clinical trials of behavioral interventions.
Journal of Nursing Scholarship 2007, 39(3):214-221.
32. Lovibond PF, Lovibond SH: The structure of negative emotional states:
comparison of the Depression Anxiety Stress Scales (DASS) with the
Beck Depression and Anxiety Inventories. Behaviour Research and Therapy
1995, 33(3):335-343.
33. Grant AM, Franklin J, Langford P: The Self-Reflection and Insight Scale: a
new measure of private self-consciousness. Social Behavior and Personality
2002, 30(8):821-836.
34. Treynor W, Gonzalez R, Nolen-Hoeksema S: Rumination reconsidered: a
psychometric analysis. Cognitive Therapy and Research 2003, 27:247-259.
35. Mayer JD, Stevens AA: An emerging understanding of the reflective
(meta-) experience of mood. Journal of Research in Personality 1994,
28:351-373.
36. Ware JE, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity.
Medical Care 1996, 34(3):220-233.
37. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M: Development
of the Alcohol Use Disorders Identification Test (AUDIT): WHO
Collaborative Project on Early Detection of Persons with Harmful
Alcohol Consumption–II. Addiction 1993, 88(6):791-804.
38. Patton GC, Hibbert M, Rosier MJ, Carlin JB, Caust J, Bowes G: Patterns of
common drug use in teenagers. Australian Journal of Public Health 1995,
19(4):393-399.
39. Frydenberg E, Lewis R: Adolescent coping: the different ways in which
boys and girls cope. Journal of Adolescence 1991, 14(2):119-133.
40. Frydenberg E, Lewis R: Boys play sport and girls turn to others: age,
gender and ethnicity as determinants of coping. Journal of Adolescence
1993, 16(3):253-266.
41. Mead N, Bower P, Roland M: The General Practice Assessment
Questionnaire (GPAQ)-development and psychometric characteristics.
BMC Family Practice 2008, 9:13.
42. TalkingCure.com. .
43. PARTY Project. [http://www.party.unimelb.edu.au].
44. Appraisal Record of Senior House Officer. [http://www.webcitation.org/
query.php?url=http://www.rcplondon.ac.uk/pubs/contents/304a5fdc-cc4e-
4d3e-8270-49403e35fe8e.pdf&refdoi=10.1186/1472-6920-8-22].
45. Cohen J: A power primer. Psychological Bulletin 1992, 112(1):155-159.
46. Reid S, Patton G, Sanci L, Kauer S: Understanding how young people cope
with distress: the development of a mobile phone momentary sampling
program (Mobile_TYPE). Acta Neuropsychiatrica 2006, 18:268.
47. Hedeker D, Gibbons RD: Application of random-effects pattern-mixture
models for missing data in longitudinal studies. Psychological Methods
1997, 2(1):64-78.
48. 8570.0 Health Care Services, 2009-10: Regional characteristics. [http://
www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/8570.02009-10?
OpenDocument].
49. 1301.0 Year Book Australian, 2004: How many people live in Australia’s
remote areas?. [http://www.abs.gov.au/ausstats/abs@.nsf/Previousproducts/
1301.0Feature Article22004?opendocument&tabname=Summary&prodno=
1301.0&issue=2004&num=&view=].
50. Fritz MS, MacKinnon DP: Required sample size to detect the mediated
effect. Psychological Science 2007, 18(3):233-239.
51. Cohen J: Statistical power analysis for the behavioral sciences. Hillside,
NJ: Erlbaum; 1988.
52. Kauer SD, Reid SC, Crooke AHD, Khor A, Hearps SJC, Jorm AF, Sanci L,
Patton G: Self-monitoring using Mobile Phones in the Early Stages of
Adolescent Depression: A Randomised Controlled Trial with an Attention
Comparison Group to Examine The Mediating Effect of Emotional Self-
Awareness. Journal of Medical Internet Research .
53. Longwell BT, Turax P: The differential effects of weekly, monthly, and
bimonthly administrations of the Beck Depression Inventory-II:
psychometric properties and clinical implications. Behavior Therapy 2005,
36:265-275.
54. Jorm AF, Duncan-Jones P, Scott R: An analysis of the re-test artefact in
longitudinal studies of psychiatric symptoms and personality. Psychol
Med 1989, 19(2):487-493.
55. Walker Z, Townsend J, Oakley L, Donovan C, Smith H, Hurst Z, Bell J,
Marshall S: Health promotion for adolescents in primary care:
randomised controlled trial. BMJ 2002, 325(7363):524.
56. Churchill R, Allen J, Denman S, Williams D, Fielding K, von Fragstein M: Do
the attitudes and beliefs of young teenagers towards general practice
influence actual consultation behaviour? Br J Gen Pract 2000,
50(461):953-957.
57. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F: Biological, clinical, and
ethical advances of placebo effects. Lancet 2010, 375(9715):686-695.
58. Puffer S, Torgerson DJ, Watson J: Evidence for risk of bias in cluster
randomised trials: review of recent trials published in three general
medical journals. British Medical Journal 2003, 327:785-789.
59. Fritz MS, MacKinnon DP: Required sample sizr to detect the mediated
effect. Psychological Science 2007, 18(3):233-239.
Reid et al. BMC Family Practice 2011, 12:131
http://www.biomedcentral.com/1471-2296/12/131
Page 12 of 1360. Hayes AF: Beyond Baron and Kenny: Statistical mediation analysis in the
new milennium. Communication Monographs 2009, 76(4):408-420.
61. Gilbody S, Whitty P, Grimshaw J, Thomas R: Educational and
organizational interventions to improve the management of depression
in primary care: a systematic review. JAMA 2003, 289(23):3145-3151.
62. WHO: The World Health Report 2001: Mental Health: New
Understanding, New Hope. Geneva: World Health Organisation; 2001.
63. Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unützer J,
Miranda J, Carney MF, Rubenstein LV: Impact of disseminating quality
improvement programs for depression in managed primary care: a
randomized controlled trial. JAMA 2000, 283(2):212-220.
64. Rubenstein LV, Jackson-Triche M, Unützer J, Miranda J, Minnium K,
Pearson ML, Wells KB: Evidence-based care for depression in managed
primary care practices. Health Aff (Millwood) 1999, 18(5):89-105.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2296/12/131/prepub
doi:10.1186/1471-2296-12-131
Cite this article as: Reid et al.: A mobile phone application for the
assessment and management of youth mental health problems in
primary care: a randomised controlled trial. BMC Family Practice 2011
12:131.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Reid et al. BMC Family Practice 2011, 12:131
http://www.biomedcentral.com/1471-2296/12/131
Page 13 of 13